THU PHAM: Open Payments
NPI 1184390585 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 58 payments from 17 companies in 2025. Trend: 2023 $1,360 · 2024 $931 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 18 | $386 |
| Novo Nordisk Inc | 6 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| Exact Sciences Corporation | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Amgen Inc. | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Astellas Pharma US Inc | 2 | $45 |
| Mannkind Corporation | 2 | $42 |
Products named: Kerendia, Cologuard Collection Kit, SPRAVATO, OTEZLA, LEQVIO, Veozah, AFREZZA, Rybelsus.
Industry payments across NV — which companies pay providers there.
